CADL
Candel TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
CADL vs peer average
76/100
CADL vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 3 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Small-cap biopharma comparator of similar market-cap scale; useful for sector risk appetite, but not a direct prostate-cancer or viral-immunotherapy peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CADL
Candel Therapeutics
ABUS
Arbutus Biopharma
Grade
A
B
Momentum
95
64
Value
41
56
Sentiment
86
70
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABUS
CADL / ABUS
Grade Position
Above peers
CADL vs. peer average (A vs. C)
76/100
Momentum
95
CADLValue
41
ABUSSentiment
86
CADLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CADL
ABUS is the first peer returned for this comparison set.